Is your teenager skipping breakfast? Why is that happening and what can you do? As per the data from the Centers for Disease Control and Prevention (CDC), which surveyed adolescent health and well-being found that 1 in 4 students in high school ate breakfast, which means 3 in 4 high school students are not eating their breakfast. This data is as per the 2023 survey.

What Did The Study Intend?

The report describes a 10-year long trend and also recent changes among the two years. The study delved deeper into adolescents' dietary, physical activity and sleep behaviors. The study is also based on a national youth risk behavior survey of a representative sample of students from grade nine to 12.

What Did The Study Find?

The study found that while high school students drank slightly less soda and sports drinks and consumed more water, other healthy eating habits declined. In 2023, only 27% of students ate breakfast every day in the past week. The numbers were even lower for female students, with just 22% eating breakfast daily, compared to 32% of male students. Boys were also more likely to eat fruits and vegetables daily and drink water at least three times a day. Poor mental health and lack of physical activity have also been linked to skipping breakfast.

The other findings included a survey across 10-year period, where a decrease in the percentage of students eating fruits from 65% to 55%, eating vegetables, from 61% to 58%, and having breakfast daily from 38% to 27% was noted.

However, there was a positive trend among this, which was in children drinking plain water at least three times a day, which increased from 49% to 54% from when the survey began in 2015.. There were fewer students who also said that they drank soda in 2023 than in 2013. On an average, in 2013, around 22% students avoided soda, whereas in 2023, 31% students avoided it.

The report also emphasized that a healthy diet, along with daily physical activity and sufficient sleep further contributes to a healthy lifestyle. “The 10-year trends from 2013 to 2023 also show a decline in healthy dietary, physical activity, and sleep behaviors,” the survey reported.

Why Do High School Students Skip Breakfast?

While there is no one straightforward answer to it, psychologists and those who study children, believe that for many high school going kids, it is the easiest time to skip a meal. This is because they are caught between rushing to school, or not just that hungry in the morning. So for them, to sit down to have a breakfast may seem hassle and something they would have to take time out from their busy schedule. They at this age also prioritize their extra-curricular activities.

There has also been a shift in their circadian rhythm, and most teens cannot fall asleep before 11 pm, or even at midnight. Which means they wake up tired and struggle to do things right in the morning, which is why they choose to skip breakfast or give extra minutes to any other activities.

There is of course another, more popular reason, to lose weight. While experts and studies, like the one published in the Journal of Nutrition that found skipping breakfast leads to higher levels of hunger hormones, the students still feel the need to do this. However, it could lead to a slow metabolism, prompt the body to conserve energy and burn fewer calories, weight gain and deprive yo off the essential nutrients like calcium, iron, and vitamin D.

Without a morning breakfast, your blood sugar might drop too, which can increase irritability and stress, along with including the risk of depression in teenage.

A trendy “plant tonic” that promises focus and relaxation is quietly becoming a public health concern. Walk into a gas station or vape shop in many parts of the United States and you’ll see them lined up near the counter little blue bottles with the words Feel Free printed on the label. Marketed as a natural way to boost mood, productivity, and focus, the two-ounce shots look as harmless as kombucha or an energy drink. But behind their wellness branding lies an ingredient that doctors, regulators, and recovering users say can wreak havoc: kratom.

What began as a boutique herbal tonic has grown into a nationwide phenomenon. And for some people, that harmless-looking bottle has led to cycles of dependency, debt, and even rehab.

Feel Free is made by Botanic Tonics, a Texas-based company that launched the product in 2020. Its formula blends two herbal ingredients: kava root, traditionally used in Pacific Island cultures for relaxation, and kratom, a Southeast Asian plant with stimulant and opioid-like properties.

At first glance, it seems to fit right into America’s booming functional beverage market. The company advertises it as a caffeine-free energy boost and stress reliever “plant ingredients for productivity and focus.” It’s now sold in more than 24,000 convenience stores, smoke shops, and health food outlets across the country. Priced between $8 and $13 a bottle, the drink has become popular among students, young professionals, and even parents looking for a “natural” alternative to alcohol or coffee.

But what the label doesn’t highlight is the risk of dependence. Feel Free comes with a serving suggestion of one ounce, half a bottle, and a warning that it “may be habit-forming.”

What Are Kratom's Effects?

Kratom, scientifically known as Mitragyna speciosa, has been used in Southeast Asia for centuries. Laborers chewed its leaves for energy, while traditional healers brewed it as a tea for pain or diarrhea.

In the US, kratom began appearing in the late 1990s and quickly developed a following among people looking for alternatives to opioids or antidepressants. Today, nearly 2 million Americans are estimated to use kratom in some form — powders, capsules, extracts, or beverages like Feel Free.

The problem lies in how kratom interacts with the brain. Its alkaloids, primarily mitragynine, bind to the same receptors as opioids. At low doses, kratom can act like a stimulant. At higher doses, it produces sedative and euphoric effects. The U.S. Food and Drug Administration (FDA) has classified it as an opioid, citing risks of dependence, withdrawal, liver damage, and — in rare cases — overdose.

Despite these warnings, kratom remains unregulated at the federal level. Only a handful of states, including Alabama, Indiana, and Rhode Island, have banned it outright. In much of the country, it can be purchased legally by anyone, including minors, from gas stations and corner shops.

Why Has Social Media Sparks Alarm on Feel Free Drink?

Awareness of Feel Free’s addictive potential gained traction on TikTok, where users shared cautionary tales of dependency. In one viral video, Texas resident Misha Brown recounted being approached by a teenager who tried to convince him to buy Feel Free from a Circle K store. When he refused, the boy attempted to grab his wallet.

Inside the store, Brown said the attendant explained that customers came in “six times a day” for the product. The video, which garnered more than 23 million views, ignited a wave of comments from young people describing their own struggles with Feel Free — from financial strain to full-blown withdrawal symptoms.

For many, what started as an occasional pick-me-up quickly escalated into a daily habit.

Feel Free: Addiction and Health Risks

Addiction medicine specialists are now sounding the alarm. Dr. Robert Levy, an associate professor at the University of Minnesota Medical School, has treated numerous patients for kratom dependency. Withdrawal symptoms can mirror those of opioids: nausea, sweating, insomnia, irritability, and severe cravings.

The risk is compounded by Feel Free’s formula. While kratom stimulates, kava depresses the nervous system. Each herb acts on different receptors in the brain, kava on the same ones as benzodiazepines like Xanax, and kratom on opioid receptors. Combined, they can create an overstimulating and destabilizing effect that heightens the likelihood of dependence.

Some users report drinking multiple bottles a day, far exceeding the recommended limit. The cost alone can lead to financial stress, while abrupt attempts to quit often result in withdrawal that drives people back to the drink.

Regulation and Legal Gray Areas

The FDA has repeatedly warned against kratom use, but it remains stuck in regulatory limbo. In 2016, the Drug Enforcement Administration (DEA) proposed classifying kratom’s compounds as Schedule I drugs, alongside heroin and LSD, but backed down after intense lobbying from advocacy groups.

More recently, the FDA recommended tighter control of products containing 7-OH, a synthetic kratom derivative with even higher abuse potential. But Feel Free contains natural kratom leaf extract, which falls outside those recommendations.

Meanwhile, Botanic Tonics has faced lawsuits over claims that its marketing misled customers about potential risks. In 2024, the company agreed to a class-action settlement, though it did not admit wrongdoing. It has since updated labels to emphasize warnings — but insists the drink is safe when used as directed.

Why Is Kratom-Based Drinks Growing Public Health Debate?

The popularity of Feel Free highlights a larger issue: the booming U.S. market for “natural” supplements that skirt the edges of regulation. Unlike prescription medications, products like kratom tonics are not required to undergo rigorous clinical trials or FDA approval before hitting shelves.

That leaves consumers with little reliable information about safety, dosage, or long-term effects. And when a product is packaged like an energy shot, sold next to candy and soda, and advertised as a wellness aid, it’s easy for people — especially young ones — to underestimate its risks.

Should Drinks Feel Free With Kratom Be Better Regulated?

Experts say more research is urgently needed. While some studies suggest kratom may have therapeutic potential for pain management or opioid withdrawal, the risks of dependence and misuse cannot be ignored.

For now, consumers are largely left to navigate the market on their own. Health officials advise those struggling with Feel Free or other kratom products to seek professional help, either through their primary care provider or addiction treatment programs.

Parents are encouraged to talk openly with their children about kratom and similar substances. Signs of use may include mood swings, social withdrawal, digestive issues, or unexplained financial strain.

Feel Free was launched as a lifestyle drink for relaxation and focus, but its addictive potential has become impossible to ignore. It sits at the intersection of America’s appetite for quick fixes, the booming supplement industry, and gaps in regulation.

What looks like a harmless blue bottle can, for some, become the start of a struggle with dependence. Until stronger oversight and clearer science emerge, consumers are left with a difficult truth: “natural” does not always mean safe.

GLP-1 agonists like Ozempic and Wegovy have been under the spotlight as breakthrough drugs for type 2 diabetes and obesity. The medicines, developed from semaglutide, revolutionized physicians' methods of treating blood sugar and weight, benefiting millions in terms of their metabolic health. A new contender, ecnoglutide, has just shown in a phase 3 clinical trial that it could offer even more potent benefits particularly when it comes to weight loss.

Published in The Lancet Diabetes & Endocrinology, the study adds to a rapidly growing body of research suggesting that next-generation GLP-1 drugs may not just equal but surpass existing therapies.

What Is Ecnoglutide?

Similar to semaglutide and dulaglutide, ecnoglutide is a class of GLP-1 receptor agonists. What sets ecnoglutide apart is its selective targeting of the cAMP pathway. These drugs imitate the effect of glucagon-like peptide-1, a hormone responsible for controlling blood sugar and hunger. In stimulating insulin secretion, delaying digestion, and suppressing appetite, GLP-1 medications have become key in the treatment of type 2 diabetes and have also triggered substantial weight reduction.

How Does Ecnoglutide Work?

What distinguishes ecnoglutide is its selective inhibition of the cAMP pathway. This is the most critical mechanism of GLP-1's desirable effects. Current GLP-1 medications broadly act on several cellular pathways, at times producing undesired side effects. Ecnoglutide's more focused action could provide similar or improved benefits with fewer off-target effects, potentially being both more effective and better tolerated.

To test ecnoglutide, scientists performed a 52-week, randomized, phase 3 trial in 52 Chinese hospitals. The study enrolled 621 adults aged 18 to 75 with type 2 diabetes who were already on metformin, the current first-line treatment. Participants were randomly assigned to receive either:

Ecnoglutide at 0.6 mg or 1.2 mg, or

Dulaglutide at 1.5 mg, another commonly used GLP-1 agonist.

The primary goal was to measure changes in HbA1c, a marker of long-term blood sugar control, after 32 weeks. Safety, weight loss, and other cardiovascular risk markers were also tracked.

Both medications reduced blood sugar equally as well, demonstrating that ecnoglutide is on par with dulaglutide. But as for weight loss, the outcome was more dramatic. People taking ecnoglutide lost nearly twice the weight of those taking dulaglutide. On average, they also experienced greater decreases in:

• Waist and hip size
• Triglycerides (a form of fat associated with risk of heart disease)
• Significantly, these benefits were achieved with lower doses of ecnoglutide than with dulaglutide, which suggests higher efficiency and potentially lower costs of treatment.
• Side effects were mild and well known to anyone tracking GLP-1 drug studies—primarily nausea and diarrhea—and tended to dissipate as patients adjusted to the drug.

Osteoarthritis notwithstanding, type 2 diabetes and obesity are still two of the most urgent global health emergencies. Per the CDC, there are more than 37 million Americans who have diabetes and over 42% of U.S. adults with obesity. The two are strongly associated with heart disease, stroke, and lower life expectancy.

Though lifestyle approaches like diet and exercise continue to be paramount, medications like semaglutide and now ecnoglutide provide a potent medical intervention for those who cannot get adequate effects from lifestyle alone. The fact that ecnoglutide potentially surpasses an already proven GLP-1 drug suggests it could become a significant tool in the treatment armory.

Is Ecnoglutide the Next Ozempic?

It's early days yet. This was the initial phase 3 study of ecnoglutide, and it was of particular patients with type 2 diabetes in China. Additional research, particularly in heterogeneous populations and head-to-head comparison with semaglutide (Ozempic, Wegovy), is required to establish its benefits.

Scientists also will investigate how ecnoglutide works with other diabetes medicines and if it may have similar long-term risks as GLP-1 drugs, such as effects on the pancreas or eyes.

Nonetheless, that ecnoglutide had equivalent blood sugar control and better weight loss than dulaglutide in such a high-stakes trial is a strong indication of its promise.

Accessibility and Cost Considerations

One of the criticisms for existing GLP-1 drugs is that they are very expensive and have a low availability, and this has limited access even in rich countries such as the U.S. The scientists who developed ecnoglutide hope it will be less expensive and simpler to make, potentially making it more accessible around the world if approved for use internationally.

This would be a major benefit, particularly in low- and middle-income nations where diabetes prevalence is rising but resources to support advanced treatments are limited.

The pharmaceutical sector is in the midst of an ecnoglutide boom, with firms competitively developing and optimizing these treatments. The triumph of ecnoglutide gives that trend further momentum, implying that we are merely just starting to discover the potential of GLP-1 biology.

For the time being, patients and doctors will have to hold their breath until bigger, multi-nation trials have been completed before ecnoglutide enters the popular lexicon. But to date, the signs are encouraging: a medication that can decrease blood glucose, have a greater weight-reduction effect, and quite possibly be more cost-effective than current drugs.

As the authors of the study said, "Ecnoglutide may serve to fill some unmet needs in type 2 diabetes treatment and constitute an advance in diabetes therapy."

Ecnoglutide's phase 3 trial has provided the medical world with a preview of the future of diabetes and obesity care. If subsequent research holds true, it may join or even exceed Ozempic and Wegovy as a first-line treatment. For millions of people with weight and blood sugar issues, that would be more than just longer lives – it would be healthier lives.

The recent decline in the beloved actor Bruce Willis’ health has affected many people. The legendary actor has now been struggling with frontotemporal dementia for the past three years. His wife, Emma Hemmings has been vocal about caregivers and their health, has been sharing updates with his fans. In a recent interview with ABC News, she shared that Bruce is still mobile and in good health, “It's just his brain that is failing him”

Bruce Willis Dementia History: Diagnosis And Initial Struggles

In 2023, Willis's family publicly announced that he had been diagnosed with frontotemporal dementia (FTD). This type of dementia can change a person's personality and behavior. Emma Heming Willis has written a new book, "The Unexpected Journey: Finding Strength, Hope, and Yourself on the Caregiving Path," to share her family's experience.

She described her early days as a caregiver as feeling like she had to do everything alone. She would stay up at night to make sure her husband was safe and would avoid social gatherings to make things easier for him. This experience led her to become an advocate for other caregivers, and she hopes her book can be a helpful guide for them.

How Does Caring For Dementia Patients Affect Caregivers?

Caregivers are often overlooked among people to be care for. According to a 2022 study published in the International Psychogeriatrics journal, in the U.S. alone, over 15.5 million people provide unpaid care for someone with dementia. Globally, the amount of time spent on this care is equal to more than 40 million full-time jobs, and this number is expected to grow.

Why Caregivers Need To Be The Ones Cared For As Well

Caregivers for people with dementia are often called the "invisible second patients" because they face so many challenges themselves. While some caregivers feel a sense of pride or satisfaction, many also experience high levels of stress, burnout, anxiety, and depression.

Studies show that nearly half of all caregivers feel a significant burden, and about one-third show signs of depression and anxiety. This emotional stress can lead to physical health problems, like chronic inflammation, which increases the risk of heart disease and other illnesses.

Recently, some experts have suggested changing the term "caregiver" to "care partner." This change highlights the idea that caring for someone with a long-term illness should be a partnership. This new term recognizes that the person with the disease also plays an important role in their own care. While this is a great idea, it can be hard to apply to people with advanced dementia who can no longer make their own decisions.

How Can We Tackle Caregiver’s Fatigue?

The 2022 study explained that a collection of seven new studies from different countries looked at various aspects of caregiving for people with dementia.

Caregiver Burden

An Irish study found that caregivers for people with dementia are much more likely to feel overwhelmed than those caring for older people with other health issues.

Preventing Nursing Home Admission

A Norwegian study found that when caregivers feel stressed and unable to cope, it is a major reason for moving a person with dementia into a nursing home sooner.

The Power of Compassion

An international study explored the role of compassion—both for oneself and for others—in helping caregivers.

Focusing on the Positive

Researchers in the UK reviewed studies on the positive side of caregiving, like a caregiver's resilience and sense of accomplishment.

Finding the Right Support

A Danish study developed a new tool to help identify what kind of support a caregiver needs. This could help create personalized support plans.

Exercise as a Solution

A Spanish study showed that a nine-month exercise program had a positive effect on caregivers, reducing their stress and risk of depression.

Making Interventions Accessible

A U.S. study found that caregivers were willing to pay for programs that taught them skills to better manage dementia symptoms. This suggests new ways to make these helpful programs available to more families.